4-Methylmorpholine → (S)-benzyl 2-((S)-2-(2-(4-hydroxypiperidin-1-yl)acetamido)propanamido)-3-(4-methoxyphenyl)propanoate
反応式
[OH:1][CH:2]1[CH2:7][CH2:6][N:5]([CH2:8][C:9]([OH:11])=O)[CH2:4][CH2:3]1.[NH2:12][C@@H:13]([CH3:37])[C:14]([NH:16][C@@H:17]([CH2:28][C:29]1[CH:34]=[CH:33][C:32]([O:35][CH3:36])=[CH:31][CH:30]=1)[C:18]([O:20][CH2:21][C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1)=[O:19])=[O:15].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN1CCOCC1>ClCCl.O>[OH:1][CH:2]1[CH2:3][CH2:4][N:5]([CH2:8][C:9]([NH:12][C@@H:13]([CH3:37])[C:14]([NH:16][C@@H:17]([CH2:28][C:29]2[CH:30]=[CH:31][C:32]([O:35][CH3:36])=[CH:33][CH:34]=2)[C:18]([O:20][CH2:21][C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)=[O:19])=[O:15])=[O:11])[CH2:6][CH2:7]1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of 2-(4-hydroxypiperidin-1-yl)acetic acid (0.41 g, 2.6 mmol) and (S)-benzyl 2-((S)-2-aminopropanamido)-3-(4-methoxyphenyl)propanoate (HCl salt, 0.93 g, 2.6 mmol) in dichloromethane (30 mL) at 0° C. was added HATU (1.1 g, 2.9 mmol) followed by N-methylmorpholine (1.05 g, 10.4 mmol). The reaction mixture was allowed to warm to ambient temperature and stirred for 1 h. Water (30 mL) was added and the resulting mixture was extracted with dichloromethane (30 mL×3). The organic extracts were combined, dried over anhydrous sodium sulfate, and concentrated. The residue was purified by flash column chromatography on silica gel (petroleum ether/dichloromethane=5:1 to 1:1) to afford (S)-benzyl 2-((S)-2-(2-(4-hydroxypiperidin-1-yl)acetamido)propanamido)-3-(4-methoxyphenyl)propanoate (1.1 g, 87% yield) as a colorless solid.
後処理
- extractionthe resulting mixture was extracted with dichloromethane (30 mL×3)
- dry with materialdried over anhydrous sodium sulfate
- concentrationconcentrated
- customThe residue was purified by flash column chromatography on silica gel (petroleum ether/dichloromethane=5:1 to 1:1)
出典と根拠
- ORDレコード
- ord-bee3b889c20c4fd0926f4ca805d1d0a7
- 出典データセット
- uspto-grants-2016_09
- 特許番号
- US09434761B2
反応ノート
読み込み中…